Contrarian Corpus
activist research note follow up
2023-06-01 · 3 pages

Alexandria Real Estate Equities, Inc. ARE

Alexandria's life-science office portfolio is being hit by the same WFH hurricane as traditional offices, and shares face 30-40% downside if re-rated to coastal office REIT peers.

N 3 Narrative
V 4 Visual
C 4 Craft
Source URL unavailable

Thesis

Land & Buildings argues that Alexandria Real Estate Equities (ARE), the dominant life-science REIT, is suffering the same secular work-from-home shock as traditional office landlords, and the market has not yet priced it in. Real-time CoStar data shows total available space in ARE's same-store portfolio (the ~70% of lab/office assets built or redeveloped pre-2019) has doubled from 9% at YE 2021 to 18% currently, with sublease space tripling from 3% to 9%. Placer.ai cell-phone geolocation data shows attendance is down ~50% versus pre-pandemic across the same-store base, and Boston, San Francisco and San Diego — ~75% of revenue — are all deteriorating. Combined with new supply, scarce capital and lagged tenant decisions, L&B sees 30-40% downside if ARE is valued like coastal office REIT peers (BXP, DEI, ESRT, HPP, KRC, PGRE, SLG, VNO).

SCQA

Situation

Alexandria Real Estate Equities (ARE) is the dominant life-science REIT, owning and operating more than 40 million square feet of lab/office space concentrated in Boston, San Francisco and San Diego.

Complication

Cell-phone geolocation data shows same-store attendance down ~50% vs pre-pandemic and CoStar data shows total available space doubling from 9% to 18% since YE 2021, with new supply landing into a much weaker market.

Resolution

Investors should re-rate ARE in line with traditional coastal office REITs that are already absorbing the full impact of WFH on leasing and financing fundamentals, rather than crediting the life-science premium.

Reward

If valued on the implied cap rates and AFFO multiples of coastal office peers (BXP, DEI, ESRT, HPP, KRC, PGRE, SLG, VNO), Alexandria shares could decline 30-40% from current levels.

The three reasons

  1. 1

    Total available space in Alexandria's same-store portfolio doubled from 9% to 18% since YE 2021

  2. 2

    Cell-phone geolocation data shows attendance at ARE's same-store properties down ~50% vs pre-pandemic

  3. 3

    Shares could decline 30-40% if valued like coastal office REIT peers (BXP, SLG, VNO, etc.)

KPIs cited

Total available space (same-store)
Rose from 9% at YE 2021 to 18% currently
Sublease space available
Rose from 3% at YE 2021 to 9% currently
Direct space available
Rose from 6% at YE 2021 to 9% currently
Same-store attendance (Placer.ai)
Down ~50% vs pre-pandemic
Boston availability
Rose from 13% at YE 2021 to 21% currently
San Francisco availability
Rose from 11% at YE 2021 to 18% currently
San Diego availability
Rose from 3% at YE 2021 to 9% currently
Implied downside vs peer REITs
30-40% on implied cap rate and AFFO multiple basis

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Precedents cited

  • L&B May 2020 white paper 'The New York Office Market is Facing an Existential Hurricane'
  • L&B June 16, 2023 white paper 'The Work From Home Hurricane Has Hit Life Science Offices'

Notable slides (2)

Notes

Update #1 to L&B's June 16, 2023 white paper on life-science office WFH risk. Bearish thesis on ARE — there is no 'overvaluation' enum value, so thesis_types is set to 'other'. Disclosure states L&B funds 'beneficially own and/or have an economic interest in' both Alexandria and Healthpeak securities, but specific stake size and direction (long vs short) are not disclosed. Document is a 3-page white-paper update with two clean editorial chart pages plus legal disclaimer; no closing ask, no named villain, no individual signatory.